Results 41 to 50 of about 12,963 (197)

The Use of Combination Palliative Radiotherapy and Single‐Agent Immunotherapy for the Management of Head and Neck Squamous Cell Carcinoma (HNSCC) in the United Kingdom (UK)

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Clinical data on combined Immunotherapy (IO) and palliative radiotherapy (RT) in HNSCC is scarce. HNSCC Palliative RT differs from curative intent RT as it does not involve elective nodal irradiation; therefore, an immune response may be more likely.
Chris Hurt   +21 more
wiley   +1 more source

Implementación de Radiocirugía Extracraneana (SBRT) [PDF]

open access: yes, 2017
Se realizó la implementación de la técnica de radiocirugía extracraneana (SBRT) en un acelerador linal Clinac iX para su uso en tratamientos de altas dosis, en el área de radioterapia del Instituto de Oncología "Carlos Ardila Lülle" del Hospital ...
Cabrera Salcedo, Jaime Hipólito
core  

TACE-DEB vs. SBRT for hepatocellular carcinoma

open access: yes, 2023
: Purpose To compare transarterial chemoembolization delivered with drug eluting beads (TACE-DEB) with stereotactioc body radiation therapy (SBRT) in patients with hepatocellular carcinoma (HCC) in a multicenter randomized trial.
d'Archambeau, Olivier   +21 more
core  

The subgroup meta-analysis of 1-year OSR, 2-year OSR, and ORR in regard to study type, control group, treatment order, SBRT-TACE interval between SBRT plus TACE group and monotherapy group.

open access: yes, 2022
The subgroup meta-analysis of 1-year OSR, 2-year OSR, and ORR in regard to study type, control group, treatment order, SBRT-TACE interval between SBRT plus TACE group and monotherapy group.
Xu-quan Lu (12575240)   +7 more
core   +1 more source

Hypervision Proton Surgery: The Future Direction of Proton Therapy

open access: yesiNew Medicine, EarlyView.
ABSTRACT Proton beams provide unique physical advantages characterized by a low entrance dose, negligible exit dose, and a sharp Bragg peak, which enable superior sparing of normal tissues and support safe dose escalation for improved tumor control. However, conventional photon‐based fractionation remains widely used in proton therapy, where prolonged ...
Li Li, Shuanghu Yuan
wiley   +1 more source

PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRT [PDF]

open access: yes
PACE-NODES is a phase III randomised controlled trial for patients with high risk localised prostate cancer, planned for radical radiotherapy with at least 12 months of androgen deprivation therapy, and suitable for stereotactic body radiotherapy (SBRT).
Cafferty, Fay H.   +43 more
core   +1 more source

Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review

open access: yesCost Effectiveness and Resource Allocation, 2020
Stereotactic body radiotherapy (SBRT) is a novel noninvasive treatment for hepatocellular carcinoma. SBRT can achieve effective local control, but it requires a relatively high input of resources; this systematic review was performed to assess the cost ...
Haiyin Wang   +5 more
doaj   +1 more source

Abscopal effect in metastatic breast cancer treated with stereotactic body radiotherapy in the absence of immunotherapy

open access: yesFrontiers in Oncology, 2023
PurposeIn this study, we aimed to assess the abscopal effect (AE) after CyberKnife stereotactic body radiotherapy (SBRT) in metastatic breast cancer patients without immunotherapy.MethodsWe reviewed breast cancer patients who received SBRT with a ...
Jae Sik Kim, Ah Ram Chang
doaj   +1 more source

SBRT pancreas

open access: yes, 2022
Introduction: In order to deliver a better and better dose to the region of interest, the SBRT method of pancreatic irradiation was introduced. Goal: Precise delivery of a high dose to a small volume with a small number of fractions. The role of the radiotherapy technician during each segment of the entire process, as well as all the specifics of the ...
openaire   +1 more source

AI‐Driven Rational Design of Nanotherapeutics for Pancreatic Ductal Adenocarcinoma

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) remains a formidable malignancy characterized by late diagnosis, high recurrence rates, and pronounced chemoresistance. While nanoparticle‐based drug delivery systems (NDDS) offer theoretical advantages over conventional therapies, their clinical translation in PDAC has been severely limited.
Seohyun Choo   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy